Search
Boston Scientific Corp
BSXAdd to Watchlist
45.290USD
+0.350+0.78%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
67.31BMarket Cap
18.84P/E TTM
Revenue Breakdown
Currency: USDUpdated: Thu, Apr 2
Currency: USDUpdated: Thu, Apr 2
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Interventional Cardiology Therapies
4.64B
23.11%
Electrophysiology
3.33B
16.56%
Endoscopy
2.92B
14.53%
Urology
2.71B
13.50%
Cardiac Rhythm Management
2.33B
11.62%
Other
4.15B
20.69%
By RegionUSD
Name
Revenue
Proportion
United States
12.86B
64.08%
EMEA (Europe, Middle East and Africa)
3.45B
17.19%
Asia Pacific
3.08B
15.34%
Latin America and Canada
678.00M
3.38%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Interventional Cardiology Therapies
4.64B
23.11%
Electrophysiology
3.33B
16.56%
Endoscopy
2.92B
14.53%
Urology
2.71B
13.50%
Cardiac Rhythm Management
2.33B
11.62%
Other
4.15B
20.69%
